MorphoSys's vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Events

01. Wed
August

Publication of Half-Year Report 2018

28. Tue
August

Commerzbank Sector Conference

Frankfurt, Germany
24. Mon
September

Baader Bank Germany Investment Conference

Munich, Germany

Presentations

06/20/2018
JMP Securities Life Sciences Conference
06/06/2018
dbAccess Berlin
Berlin, Germany
05/21/2018
UBS Global Healthcare Conference
New York, US
05/03/2018
Q1 Call Presentation
03/13/2018
Year-End Results 2017
Planegg, Deutschland

Corporate Communications and Investor Relations
Phone: +49 89 89927 404
Fax: +49 89 89927 5404
Email Contact